Pharmacokinetic Study of Tenofovir Disoproxil Fumarate Combined with Rifampin in Healthy Volunteers

Tenofovir disoproxil fumarate (tenofovir DF) was studied in combination with rifampin in 24 healthy subjects in a multiple-dose, open-label, single-group, two-period study. All subjects were given tenofovir DF at 300 mg once a day (QD) from days 1 to 10 (period 1). From days 11 to 20 the subjects re...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Antimicrob Agents Chemother
Autori principali: Droste, J. A. H., Verweij-van Wissen, C. P. W. G. M., Kearney, B. P., Buffels, R., vanHorssen, P. J., Hekster, Y. A., Burger, D. M.
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Microbiology (ASM) 2005
Soggetti:
Antiviral Agents
Accesso online:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC547290/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15673751/
https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.49.2.680-684.2005
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi